Publications by authors named "D Richard Lachno"

Claim this Profile
C
Central pharmacodynamic activity of solanezumab in mild Alzheimer's disease dementia.
Brian A Willis, Karen Sundell, D Richard Lachno, Lisa R Ferguson-Sells, Michael G Case

Alzheimers Dement (N Y)· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Derivation of cutoffs for the Elecsys amyloid β (1-42) assay in Alzheimer's disease.
Leslie M Shaw, Teresa Waligorska, Leona Fields, Magdalena Korecka, Michal Figurski, D Richard Lachno

Alzheimers Dement (Amst)· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydroxyphenylglycol as a Biomarker of Norepinephrine Transporter Inhibition by Atomoxetine: Human Model to Assess Central and Peripheral Effects of Dosing.
Peter R Bieck, Mark Leibowitz, D Richard Lachno, Edouard Ledent, Robert Padich

J Clin Psychopharmacol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1-42 peptide in human plasma with utility for studies of Alzheimer's disease therapeutics.
Linan Song, D Richard Lachno, David Hanlon, Adam Shepro, Andreas Jeromin

Alzheimers Res Ther· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for adaptation and validation of commercial kits for biomarker quantification in drug development.
Masood U Khan, Ronald R Bowsher, Mark Cameron, Viswanath Devanarayan, Steve Keller, D Richard Lachno

Bioanalysis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis